Enter search term

Let our Experts Help You Make the switch to ZEUS Borrelia MTTT™

Jan 13, 2021

Start the New Year right with ZEUS Borrelia MTTT™
Schedule your personalized 1:1 Lyme disease testing consultation today!

Change is easier than you think!

Are you still using immunoblots or the discontinued MarDx® Lyme disease Western blot?  If you are trying to figure out your transition plans, let us help convert to a more accurate Lyme disease testing algorithm!

With over 30 years of experience in developing and delivering high quality Lyme disease tests, we have the knowledge and experience you need to make a seamless transition to the only FDA-cleared MTTT testing paradigm available: the ZEUS Borrelia Modified Two-Tiered Testing (MTTT™) algorithm.
Let the experts in Lyme disease testing help! Make 2021 the year you join other laboratories who have made the switch to the ZEUS Borrelia Modified Two-Tiered Testing (MTTT™) algorithm.

Schedule your 1:1 consultation today!

Why make the switch?

Simpler.
ZEUS Borrelia MTTT™ uses two rounds of ELISA tests, enabling simple and flexible first-tier and second-tier testing in-house. This allows you to consolidate your Lyme disease testing processes and streamlines your workflow.

Faster.
The ZEUS Borrelia MTTT™ reduces turnaround time, allowing patients to access much-needed treatment earlier. Without early treatment, Lyme disease can have a devastating impact on patients.

Better.
Our updated algorithm detected up to 30% more clinically confirmed positive patients in acute early Lyme disease, the critical time to correctly identify and treat!  Reducing the number of missed clinically positive patient samples especially in early Lyme disease stages 1 and 2 can make a real difference in a person’s life.

 

But that's not all.

Partnering with ZEUS Scientific means partnering with over 40 years of experience in developing, manufacturing and delivering high-quality in vitro diagnostic (IVD) products. Particularly, ZEUS has been a pioneer in Lyme disease diagnostics. From the first FDA-cleared Lyme disease IVD in 1987, to the only FDA-cleared Borrelia MTTT™ algorithm method of testing for Lyme disease in 2019, it is no wonder that ZEUS has been recently featured on Lifetime Network's Access Health program.

 

Trust the experts in Lyme disease testing.
Test with Confidence. Test with ZEUS.

Simplify your testing. Contact ZEUS today!

Visit zeuslyme.com to learn more.

Best,
The ZEUS Scientific Team

Back Share